Der Pharma Chemica
Journal for Medicinal Chemistry, Pharmaceutical Chemistry, Pharmaceutical Sciences and Computational Chemistry
ISSN: 0975-413X
Abstract
A novel RP-HPLC method for quantification of tapentadol HCl in pharmaceutical formulations
Author(s): Ruhul Kayesh, Md. Sharif Hasan and Md. Zakir Sultan*A rapid and highly sensitive reversed phase high performance liquid chromatographic method was developed for quantitative estimation of tapentadol hydrochloride in pharmaceutical preparations. The method was validated according to ICH, FDA and USP guidelines with respect to accuracy, precision, specificity, linearity, robustness, sensitivity and system suitability. The method was developed by using an isocratic condition of mobile phase comprising with 60% buffer [potassium di-hydrogen phosphate (0.03 molar) and n-heptane sulphonic acid- Na salt (0.002 molar)] and 40% acetonitrile at a flow rate of 1.0 mL/min over C-18 (ODS, 250 x 4.6 mm) column at ambient temperature. The retention time was found to be at 3.7± 0.1 min. The recovery was found as >90% which demonstrated the accuracy of the protocol. Intraday and inter-day precision studies of the new method were less than the maximum allowable limit (RSD%£ 2.0 according to FDA). The method showed linear response with correlation coefficient (r2) value of 0.999. Therefore, it was found to be accurate, reproducible, sensitive and less time consuming and can be successfully applied for the assay of tapentadol hydrochloride in any pharmaceutical formulations.
Select your language of interest to view the total content in your interested language
Google Scholar citation report
Citations : 15261
Der Pharma Chemica received 15261 citations as per Google Scholar report
Der Pharma Chemica peer review process verified at publons
